These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6125642)

  • 21. Drug treatment of peptic ulcer syndrome.
    Fielding JF
    Ir Med J; 1982 Oct; 75(10):379-82. PubMed ID: 7174254
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; mucosal blood-flow improving agents].
    Shimakura S; Fukutomi H
    Nihon Rinsho; 1988 Jan; 46(1):55-63. PubMed ID: 3373758
    [No Abstract]   [Full Text] [Related]  

  • 24. Peptic ulcer disease, cytoprotection, and prostaglandins.
    Fiske SC
    Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
    [No Abstract]   [Full Text] [Related]  

  • 25. Antacids in the treatment of peptic ulcer disease.
    Garrigues-Gil V
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():73-7. PubMed ID: 2657291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of prolonged therapy with different agents on gastric acid-peptic secretion (neutralizers, antipeptics and anticholinergics).
    Mazure PA; Cosen JN
    Acta Gastroenterol Latinoam; 1973; 5(3):117-23. PubMed ID: 4601544
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oral antacids and anti-ulcer drugs: each one at its proper time].
    Navarro Ferrer F; Navarro Ferrer ME; Prieto Peraita M
    Rev Enferm; 2000; 23(7-8):499-503. PubMed ID: 10983155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible inhibitors of the gastric H+/K(+)-transporting ATPase: a new class of anti-secretory agent.
    Pope AJ; Parsons ME
    Trends Pharmacol Sci; 1993 Sep; 14(9):323-5. PubMed ID: 8249153
    [No Abstract]   [Full Text] [Related]  

  • 29. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 30. [The gastroscopic examination of Attapulgit, a colloidal silicate with antacid effect (author's transl)].
    Göbel D; Witte S
    Med Klin; 1973 Oct; 68(41):1323-6. PubMed ID: 4765402
    [No Abstract]   [Full Text] [Related]  

  • 31. Gastroprotective properties of 11-deoxymisoprostol (prostaglandin E1 analog) and its effect on the level of sialic acids in gastric tissue of rats with peptic ulcer.
    Baschenko NZh; Sapozhnikova TA; Gabdrakhmanova SF; Makara NS; Khisamutdinova RY; Zarudii FS; Ivanova NA; Nazarov VS
    Bull Exp Biol Med; 2006 Oct; 142(4):467-9. PubMed ID: 17415439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The medical management of peptic ulcer.
    Shearman DJ; Hetzel D
    Annu Rev Med; 1979; 30():61-79. PubMed ID: 45409
    [No Abstract]   [Full Text] [Related]  

  • 33. [Controversy and trends in ulcer therapy. 1: Treatment of ulcer manifestation].
    Berndt H
    Z Arztl Fortbild (Jena); 1993 Aug; 87(8):635-42. PubMed ID: 8379202
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antacids: what role in the treatment of ulcer disease?].
    Galmiche JP; Bruley des Varannes S; Ducrot F
    Gastroenterol Clin Biol; 1986; 10(6-7):481-5. PubMed ID: 2875914
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems in the traditional pharmacotherapy and prevention of peptic ulcer].
    Ryss ES
    Ter Arkh; 1984; 56(9):106-10. PubMed ID: 6393409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
    László A
    Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacology of peptic ulcer disease.
    Ippoliti A; Peterson W
    Clin Gastroenterol; 1979 Jan; 8(1):53-67. PubMed ID: 369747
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent state of therapy of peptic disease].
    Pavlotzky M; Eshchar J
    Harefuah; 1985 Nov; 109(10):288-96. PubMed ID: 3912295
    [No Abstract]   [Full Text] [Related]  

  • 39. [Microcirculation in gastric mucosa as related to its secretory activity in patients with peptic ulcer].
    Shcherbynina MB
    Lik Sprava; 2002; (5-6):24-6. PubMed ID: 12442513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Difficulties in the choice of an antacid in therapeutics].
    Bernades P
    Gastroenterol Clin Biol; 1983; 7(6-7):567-9. PubMed ID: 6873574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.